GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - Code of Conduct of Fair Disclosure

GlaxoSmithkline Consumer Healthcare Ltd the Board of Directors at their meeting held on May 08, 2015 formulated and adopted the Code of Conduct and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information of the Company in compliance with the Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015.<BR><BR>Further, the Code of Conduct and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information has also been published on the website of the Company.